ERcast: Clinical Perspectives Podcast Preview

Subscription Required

Lit Matters #3: Aggressive vs. moderate fluid use in acute pancreatitis

Matthew DeLaney, MD, FACEP, FAAEM and Charles Khoury MD, FACEP, FAAEM

Sign in or Subscribe to listen.
5 starson Spotify
Sign in or Subscribe to view.Sign in or Subscribe to view.

The summary below is from an episode of ERcast: Clinical Perspectives

Acute pancreatitis management has moved away from routine aggressive IV fluids. In early pancreatitis, a moderate lactated Ringer’s strategy lowered fluid-overload events without reducing progression to moderately severe or severe disease, a clinically important shift for ED and ICU resuscitation decisions.

Fluid Strategy in Acute Pancreatitis

  • Practice change signal: Aggressive fluid resuscitation in acute pancreatitis caused more fluid overload without improving pancreatitis severity, reinforcing the shift toward a more moderate early IV fluid approach.
  • Headline safety finding: Fluid overload was the clear harm signal, occurring in about 18% of the aggressive group versus about 8% with moderate resuscitation, enough for the trial to stop early.
  • No severity benefit: Progression to moderately severe or severe pancreatitis was not meaningfully lower with aggressive fluids, with event rates around 22% versus 17% despite substantially higher volumes.
  • Relevant study population: Adults had to meet Revised Atlanta criteria and present within 24 hours of pain onset, making the results most applicable to early uncomplicated pancreatitis in the ED.
  • Who was not studied: Patients with severe disease at presentation, heart failure, chronic renal failure, or decompensated cirrhosis were excluded, an important boundary when applying this at the bedside. We get into the generalizability nuances in the episode.
  • Volume separation achieved: The treatment arms were genuinely different: by 24 hours, median lactated Ringer’s volumes were 5.4 liters with aggressive care versus 3.3 liters with moderate resuscitation.

Subscribe to ERcast: Clinical Perspectives to listen to the episode.

Faculty